Table 1 Baseline characteristics of patients infected with COVID-19
Total (n = 156) | Survivor (n = 100) | Non-survivor (n = 56) | P valuea | |
|---|---|---|---|---|
Characteristics | ||||
Age, years | 66.0 (46.3–73.0) | 58.0 (37.0–69.0) | 72.0 (65.3–83.0) | < 0.001 |
Male, % | 76 (48.7) | 44(44.0) | 32(57.1) | 0.115 |
Underlying disease | ||||
Cardiovascular disease, % | 44 (28.2) | 17 (17.0) | 27 (48.2) | < 0.001 |
COPD, % | 27 (17.3) | 12 (12.0) | 15 (26.8) | 0.019 |
Chronic renal disease, % | 15 (9.6) | 4 (4.0) | 11 (19.6) | 0.001 |
Chronic liver disease, % | 14 (9.0) | 2 (2.0) | 12 (21.4) | < 0.001 |
Cerebrovascular, % | 22 (14.1) | 9 (9.0) | 13 (23.2) | 0.014 |
Diabetes, % | 31 (19.9) | 11 (11.0) | 20 (35.7) | < 0.001 |
Hypertension, % | 65 (41.7) | 31 (31.0) | 34 (60.7) | < 0.001 |
Cancer, % | 14 (9.0) | 3 (3.0) | 11 (19.6) | < 0.001 |
Initial symptoms | ||||
Fever, % | 79 (50.6) | 56 (56.0) | 23 (41.4) | 0.074 |
Cough, % | 71 (45.5) | 45 (45.0) | 26 (46.4) | 0.864 |
Chest tightness, % | 28 (17.9) | 16 (16.0) | 12 (21.4) | 0.397 |
Asthma, % | 30 (19.2) | 22 (22.0) | 8 (14.3) | 0.241 |
Headache, % | 5 (3.2) | 2 (2.0) | 3 (5.4) | 0.351 |
Myalgia, % | 2 (1.3) | 1 (1.0) | 1 (1.8) | 1.000 |
Chill, % | 4 (2.6) | 4 (4.0) | 0 (0) | 0.297 |
Nausea or vomiting, % | 8 (5.1) | 3 (3.0) | 5 (8.9) | 0.136 |
Fatigue, % | 23 (14.7) | 8 (8.0) | 15 (26.8) | 0.002 |
Diarrhea, % | 2 (1.3) | 1 (1.0) | 1 (1.8) | 0.359 |
Poor appetite, % | 13 (8.3) | 4 (4.0) | 9 (16.1) | 0.014 |
Disturbance of consciousness, % | 4 (2.6) | 0 (0) | 4 (7.1) | 0.015 |